ÍøºìºÚÁÏ

Skip to main content

Elias Sayour, MD, PhD

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of Elias Sayour

Research at a glance

Top areas of exploration

  • Glioblastoma , 12 publications
  • Immunotherapy , 11 publications
  • Brain Neoplasms , 10 publications
  • T-Lymphocytes , 7 publications

Research activity

56 publications

2,148 citations

Why is this important?

Focus

Active clinical trials

PBTC-060

Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells…

Investigators
Elias Sayour, Jennifer F King
Status
Accepting Candidates
Ages
1 Year - 21 Years
Sexes
All

My publications

56 publications

2019

Emerging trends in immunotherapy for pediatric sarcomas.

Journal of hematology & oncology

•

2019

Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition.

Neuro-oncology

•

2019

RNA-Modified T Cells Mediate Effective Delivery of Immunomodulatory Cytokines to Brain Tumors.

Molecular therapy : the journal of the American Society of Gene Therapy

•

2019

Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling.

Journal for immunotherapy of cancer

•

2018

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes.

International journal of molecular sciences

•